427
Type of lipodystrophy Remarks
Congenital Generalized
Berardinelli–Seip
syndrome
AGPAT2 and BSCL2 mutation
Some variants may be associated with short stature,
mental retardation, and cardiomyopathy
Partial
Familial partial
lipodystrophy
LMNA, PPARG, and AKT2 mutation
Loss of adipose tissue from extremities
Werner’s syndrome WRN mutation
Short stature and feature of progeria
Acquired Generalized
Lawrence syndrome Triggered by panniculitis or autoimmunity
Partial
Barraquer–Simons
syndrome
Lipoatrophy in upper half of the body and
lipohypertrophy in lower half of the body
Possibly autoimmune mediated or viral infection
Drugs Protease inhibitors
rhGH therapy
Insulin therapy
Pegvisomant
- What is congenital generalized lipodystrophy?
Congenital generalized lipodystrophy (CGL) also called as Berardinelli–Seip
syndrome is an autosomal recessive disorder characterized by markedly reduced
subcutaneous adipose tissue. Children with CGL have voracious appetite, accel-
erated linear growth, acromegaloid facies, protuberant abdomen, and severe
acanthosis nigricans (Fig. 12.6). Affected females commonly present with
features of hyperandrogenism. The metabolic abnormalities associated with
lipodystrophy include severe insulin resistance, diabetes mellitus, hypertriglyc-
eridemia, and low HDL-C. Diabetes associated with CGL usually manifest dur-
ing peripubertal period and is refractory to therapy with insulin and other
antidiabetic drugs. There are two variants of CGL, type1 and type2. The differ-
ences between these two subtypes are summarized in the table given below.
Parameters Type1 CGL Type2 CGL
Mutations AGPAT2 gene BSCL2 gene
Metabolically active fat (subcutaneous, intra-abdominal,
intrathoracic, intermuscular, and bone marrow)
Absent Absent
Mechanical fat (scalp, orbit, palm, and sole) Preserved Absent
Cardiomyopathy Present More
common
Mental retardation Present More
common
Focal lytic lesions in long bone More
common
Present
12 Diabetes in the Young